{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Virus du SRAS : Questions médicales les plus fréquentes",
"headline": "Virus du SRAS : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Virus du SRAS : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-05-12",
"dateModified": "2025-05-07",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Virus du SRAS"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Betacoronavirus",
"url": "https://questionsmedicales.fr/mesh/D000073640",
"about": {
"@type": "MedicalCondition",
"name": "Betacoronavirus",
"code": {
"@type": "MedicalCode",
"code": "D000073640",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B04.820.578.500.540.150.113"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "SARS-CoV-2",
"alternateName": "SARS-CoV-2",
"url": "https://questionsmedicales.fr/mesh/D000086402",
"about": {
"@type": "MedicalCondition",
"name": "SARS-CoV-2",
"code": {
"@type": "MedicalCode",
"code": "D000086402",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B04.820.578.500.540.150.113.937.500"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Virus du SRAS",
"alternateName": "Severe acute respiratory syndrome-related coronavirus",
"code": {
"@type": "MedicalCode",
"code": "D045473",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Matthew P Cheng",
"url": "https://questionsmedicales.fr/author/Matthew%20P%20Cheng",
"affiliation": {
"@type": "Organization",
"name": "McGill University Health Centre and McGill Interdisciplinary Initiative in Infection and Immunity, Montreal, Quebec, Canada (M.P.C.)."
}
},
{
"@type": "Person",
"name": "Cedric P Yansouni",
"url": "https://questionsmedicales.fr/author/Cedric%20P%20Yansouni",
"affiliation": {
"@type": "Organization",
"name": "McGill University Health Centre, McGill Interdisciplinary Initiative in Infection and Immunity, and J.D. MacLean Centre for Tropical Diseases, McGill University, Montreal, Quebec, Canada (C.P.Y., M.S., M.L.)."
}
},
{
"@type": "Person",
"name": "Michaël Desjardins",
"url": "https://questionsmedicales.fr/author/Micha%C3%ABl%20Desjardins",
"affiliation": {
"@type": "Organization",
"name": "Brigham and Women's Hospital, Boston, Massachusetts, and Centre Hospitalier de l'Université de Montréal, Montreal, Quebec, Canada (M.D.)."
}
},
{
"@type": "Person",
"name": "Sanjat Kanjilal",
"url": "https://questionsmedicales.fr/author/Sanjat%20Kanjilal",
"affiliation": {
"@type": "Organization",
"name": "Brigham and Women's Hospital and Harvard Medical School & Harvard Pilgrim Healthcare Institute, Boston, Massachusetts (S.K.)."
}
},
{
"@type": "Person",
"name": "Caroline Quach",
"url": "https://questionsmedicales.fr/author/Caroline%20Quach",
"affiliation": {
"@type": "Organization",
"name": "CHU Sainte-Justine, Université de Montréal, Montreal, Canada (C.Q.)."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Non-pharmacological and melatonin interventions for pediatric sleep initiation and maintenance problems: A systematic review and network meta-analysis.",
"datePublished": "2023-06-16",
"url": "https://questionsmedicales.fr/article/37406497",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.smrv.2023.101806"
}
},
{
"@type": "ScholarlyArticle",
"name": "The role of arts therapies in mitigating Sleep Initiation and Maintenance Disorders: a systematic review.",
"datePublished": "2024-05-16",
"url": "https://questionsmedicales.fr/article/38818021",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3389/fpsyt.2024.1386529"
}
},
{
"@type": "ScholarlyArticle",
"name": "Sleep architecture and sleep-disordered breathing in fatal insomnia.",
"datePublished": "2022-09-20",
"url": "https://questionsmedicales.fr/article/36182725",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.sleep.2022.08.027"
}
},
{
"@type": "ScholarlyArticle",
"name": "Profile of sleep disturbances in patients with recurrent depressive disorder or bipolar affective disorder in a tertiary sleep disorders service.",
"datePublished": "2023-05-31",
"url": "https://questionsmedicales.fr/article/37258713",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s41598-023-36083-7"
}
},
{
"@type": "ScholarlyArticle",
"name": "Insomnia and other sleep disorders in adolescence.",
"datePublished": "2024-07-30",
"url": "https://questionsmedicales.fr/article/39084851",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1136/bmjpo-2021-001229"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Virus",
"item": "https://questionsmedicales.fr/mesh/D014780"
},
{
"@type": "ListItem",
"position": 3,
"name": "Virus à ARN",
"item": "https://questionsmedicales.fr/mesh/D012328"
},
{
"@type": "ListItem",
"position": 4,
"name": "Virus à ARN à brin positif",
"item": "https://questionsmedicales.fr/mesh/D000085102"
},
{
"@type": "ListItem",
"position": 5,
"name": "Nidovirales",
"item": "https://questionsmedicales.fr/mesh/D028381"
},
{
"@type": "ListItem",
"position": 6,
"name": "Coronaviridae",
"item": "https://questionsmedicales.fr/mesh/D003332"
},
{
"@type": "ListItem",
"position": 7,
"name": "Coronavirus",
"item": "https://questionsmedicales.fr/mesh/D017934"
},
{
"@type": "ListItem",
"position": 8,
"name": "Betacoronavirus",
"item": "https://questionsmedicales.fr/mesh/D000073640"
},
{
"@type": "ListItem",
"position": 9,
"name": "Virus du SRAS",
"item": "https://questionsmedicales.fr/mesh/D045473"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Virus du SRAS - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Virus du SRAS",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-14",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Virus du SRAS",
"description": "Comment le SRAS est-il diagnostiqué ?\nQuels tests sont utilisés pour le SRAS ?\nLe SRAS peut-il être confondu avec d'autres maladies ?\nQuels symptômes indiquent un test pour le SRAS ?\nLes radiographies sont-elles utiles pour le SRAS ?",
"url": "https://questionsmedicales.fr/mesh/D045473?mesh_terms=Sleep+Initiation+and+Maintenance+Disorders#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Virus du SRAS",
"description": "Quels sont les symptômes courants du SRAS ?\nLe SRAS provoque-t-il des complications respiratoires ?\nLes symptômes du SRAS apparaissent-ils rapidement ?\nY a-t-il des symptômes gastro-intestinaux associés ?\nLes symptômes varient-ils d'une personne à l'autre ?",
"url": "https://questionsmedicales.fr/mesh/D045473?mesh_terms=Sleep+Initiation+and+Maintenance+Disorders#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Virus du SRAS",
"description": "Comment prévenir la transmission du SRAS ?\nLes vaccins contre le SRAS existent-ils ?\nQuelles mesures de quarantaine sont recommandées ?\nLes voyages vers des zones à risque doivent-ils être évités ?\nLes établissements de santé doivent-ils être préparés ?",
"url": "https://questionsmedicales.fr/mesh/D045473?mesh_terms=Sleep+Initiation+and+Maintenance+Disorders#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Virus du SRAS",
"description": "Quel est le traitement principal du SRAS ?\nLes antibiotiques sont-ils efficaces contre le SRAS ?\nLe traitement préventif est-il disponible pour le SRAS ?\nLes corticostéroïdes sont-ils utilisés pour le SRAS ?\nLe soutien respiratoire est-il crucial ?",
"url": "https://questionsmedicales.fr/mesh/D045473?mesh_terms=Sleep+Initiation+and+Maintenance+Disorders#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Virus du SRAS",
"description": "Quelles sont les complications possibles du SRAS ?\nLe SRAS peut-il entraîner des séquelles à long terme ?\nLes complications sont-elles plus fréquentes chez certains groupes ?\nLe SRAS peut-il causer des problèmes cardiaques ?\nLes complications neurologiques sont-elles possibles ?",
"url": "https://questionsmedicales.fr/mesh/D045473?mesh_terms=Sleep+Initiation+and+Maintenance+Disorders#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Virus du SRAS",
"description": "Qui est le plus à risque de développer le SRAS ?\nLes travailleurs de la santé sont-ils plus exposés ?\nLes voyages dans des zones à risque augmentent-ils le risque ?\nLes personnes immunodéprimées sont-elles plus vulnérables ?\nLe contact avec des animaux infectés est-il un facteur de risque ?",
"url": "https://questionsmedicales.fr/mesh/D045473?mesh_terms=Sleep+Initiation+and+Maintenance+Disorders#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment le SRAS est-il diagnostiqué ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur des tests PCR, des cultures virales et des analyses sérologiques."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour le SRAS ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests PCR et les tests sérologiques sont couramment utilisés pour détecter le virus."
}
},
{
"@type": "Question",
"name": "Le SRAS peut-il être confondu avec d'autres maladies ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, il peut être confondu avec la grippe ou d'autres infections respiratoires."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent un test pour le SRAS ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Fièvre, toux, dyspnée et antécédents de voyage dans des zones à risque sont des indicateurs."
}
},
{
"@type": "Question",
"name": "Les radiographies sont-elles utiles pour le SRAS ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les radiographies thoraciques peuvent montrer des infiltrats pulmonaires caractéristiques."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes courants du SRAS ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Fièvre, toux sèche, essoufflement, douleurs musculaires et fatigue sont fréquents."
}
},
{
"@type": "Question",
"name": "Le SRAS provoque-t-il des complications respiratoires ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, il peut entraîner une pneumonie et une détresse respiratoire aiguë."
}
},
{
"@type": "Question",
"name": "Les symptômes du SRAS apparaissent-ils rapidement ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes apparaissent généralement 2 à 7 jours après l'exposition au virus."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes gastro-intestinaux associés ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains patients peuvent présenter des diarrhées ou des douleurs abdominales."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils d'une personne à l'autre ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'intensité et la combinaison des symptômes peuvent varier selon les individus."
}
},
{
"@type": "Question",
"name": "Comment prévenir la transmission du SRAS ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le lavage des mains, le port de masques et l'évitement des contacts étroits sont essentiels."
}
},
{
"@type": "Question",
"name": "Les vaccins contre le SRAS existent-ils ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Actuellement, il n'existe pas de vaccin approuvé contre le SRAS."
}
},
{
"@type": "Question",
"name": "Quelles mesures de quarantaine sont recommandées ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les personnes exposées doivent être mises en quarantaine pour éviter la propagation."
}
},
{
"@type": "Question",
"name": "Les voyages vers des zones à risque doivent-ils être évités ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, il est conseillé d'éviter les voyages vers des zones où le SRAS est actif."
}
},
{
"@type": "Question",
"name": "Les établissements de santé doivent-ils être préparés ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les hôpitaux doivent avoir des protocoles pour gérer les cas suspects de SRAS."
}
},
{
"@type": "Question",
"name": "Quel est le traitement principal du SRAS ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il n'existe pas de traitement antiviral spécifique, le soutien respiratoire est essentiel."
}
},
{
"@type": "Question",
"name": "Les antibiotiques sont-ils efficaces contre le SRAS ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, les antibiotiques ne sont pas efficaces car le SRAS est causé par un virus."
}
},
{
"@type": "Question",
"name": "Le traitement préventif est-il disponible pour le SRAS ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Aucun traitement préventif spécifique n'est disponible, la prévention repose sur l'hygiène."
}
},
{
"@type": "Question",
"name": "Les corticostéroïdes sont-ils utilisés pour le SRAS ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les corticostéroïdes peuvent être utilisés pour réduire l'inflammation dans certains cas."
}
},
{
"@type": "Question",
"name": "Le soutien respiratoire est-il crucial ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le soutien respiratoire est vital pour les patients présentant une détresse respiratoire."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications possibles du SRAS ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent la pneumonie, l'insuffisance respiratoire et des lésions pulmonaires."
}
},
{
"@type": "Question",
"name": "Le SRAS peut-il entraîner des séquelles à long terme ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains patients peuvent avoir des séquelles respiratoires persistantes après guérison."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles plus fréquentes chez certains groupes ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes âgées et celles avec des comorbidités sont plus à risque."
}
},
{
"@type": "Question",
"name": "Le SRAS peut-il causer des problèmes cardiaques ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des études montrent que le SRAS peut affecter le cœur, entraînant des complications cardiaques."
}
},
{
"@type": "Question",
"name": "Les complications neurologiques sont-elles possibles ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des cas de complications neurologiques ont été rapportés chez certains patients atteints de SRAS."
}
},
{
"@type": "Question",
"name": "Qui est le plus à risque de développer le SRAS ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les personnes âgées et celles avec des maladies chroniques sont plus à risque."
}
},
{
"@type": "Question",
"name": "Les travailleurs de la santé sont-ils plus exposés ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les travailleurs de la santé sont à risque accru en raison de leur exposition aux patients."
}
},
{
"@type": "Question",
"name": "Les voyages dans des zones à risque augmentent-ils le risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, voyager dans des zones où le SRAS est présent augmente le risque d'infection."
}
},
{
"@type": "Question",
"name": "Les personnes immunodéprimées sont-elles plus vulnérables ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes immunodéprimées ont un risque accru de développer des formes graves de la maladie."
}
},
{
"@type": "Question",
"name": "Le contact avec des animaux infectés est-il un facteur de risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le contact avec des animaux porteurs du virus peut augmenter le risque d'infection."
}
}
]
}
]
}
McGill University Health Centre, McGill Interdisciplinary Initiative in Infection and Immunity, and J.D. MacLean Centre for Tropical Diseases, McGill University, Montreal, Quebec, Canada (C.P.Y., M.S., M.L.).
McGill University Health Centre, McGill Interdisciplinary Initiative in Infection and Immunity, and J.D. MacLean Centre for Tropical Diseases, McGill University, Montreal, Quebec, Canada (C.P.Y., M.S., M.L.).
Foundation of Innovative New Diagnostics (FIND), Geneva, Switzerland, and Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom (S.D.).
McGill Interdisciplinary Initiative in Infection and Immunity, School of Population and Global Health, McGill University, and Montreal Children's Hospital, Montreal, Quebec, Canada (J.P.).
McGill University Health Centre, McGill Interdisciplinary Initiative in Infection and Immunity, and J.D. MacLean Centre for Tropical Diseases, McGill University, Montreal, Quebec, Canada (C.P.Y., M.S., M.L.).
Sleep initiation and maintenance problems are common in the pediatric population and while behavioral interventions are recommended, their efficacy remains to be evaluated in clinical trials. We condu...
Arts therapies offer effective non-pharmacological intervention for Sleep Initiation and Maintenance Disorders (SIMDs), encompassing both passive and active modalities. This review assesses their effe...
Following PRISMA guidelines, a detailed search across PubMed, the Cochrane Library, Web of Science, and CNKI identified 17 relevant RCTs. Utilizing the Joanna Briggs Institute (JBI) quality criteria a...
Analysis shows arts therapies significantly improve sleep quality. Music therapy and meditation yield immediate benefits, while Tai Chi and Qigong require longer commitment for significant outcomes....
The link between SIMDs and mental health issues like anxiety, stress, and depression suggests arts therapies not only enhance sleep quality but also address underlying mental health conditions. The ev...
PROSPERO, ID: CRD42024506393....
Fatal insomnia (FI) is a rare prion disease severely affecting sleep architecture. Breathing during sleep has not been systematically assessed. Our aim was to characterize the sleep architecture, resp...
Eleven consecutive FI patients (ten familial, one sporadic) were examined with video-polysomnography (vPSG) between 2002 and 2017. Wake/sleep stages and respiration were evaluated using a modified sco...
Median age at onset was 48 years and survival after vPSG was 1 year. All patients had different combinations of breathing disturbances including increased respiratory rate variability (RRV; n = 7), st...
FI patients show frequent breathing alterations, associated with respiratory nuclei damage, and, in addition to NREM sleep distortion, have severe impairment of REM sleep, related with raphe nuclei de...
Bidirectional relationship between sleep disturbances and affective disorders is increasingly recognised, but its underlying mechanisms are far from clear, and there is a scarcity of studies that repo...
Sleep is important for our survival. Research suggests that getting 'good' sleep is a problem for a proportion of adolescents. The paper advocates for holistic treatment of sleep disorders incorporati...
Sleep disorders (SDs) are among many co-morbid medical conditions that affect children with autism spectrum disorder (ASD). Raising awareness and improving the standard of care for children diagnosed ...
Using the Childhood Sleep Habit Questionnaire (CSHQ) to gather data on sleep disorders and SPSS version 26.0 for data analysis, a descriptive cross-sectional study was carried out in the five main aut...
The mean age was 6.90 (± 2.6) years with a boys-to-girls ratio of 2.17:1. The prevalence of SDs (at least one sleep condition almost daily) was 95.65%. Sleep onset 71 (77.2%), limit setting 32 (32.6%)...
The frequency of SDs is significant among children diagnosed with ASD from Sudan, and certain SDs are associated with age and sex. Subsequent studies are required to develop national guidelines for th...
Sleep disorders in older adults increase with aging, likely due to increased sleep latency, decreased sleep efficiency, and total sleep time. Common sleep issues include chronic insomnia, circadian rh...
The purpose of this study was to develop and test the reliability and validity of a 13-item self-report Assessment of Sleep Environment (ASE). This study investigates the relationship between subjecti...
This study aimed to analyze the association between sleep quality and cardiovascular disease in patients on maintenance hemodialysis (MHD)....
A total of 601 patients with MHD in the second affiliated hospital of Nanjing Medical University, were prospectively enrolled in this cohort study from January 2019 to December2019. The global Pittsbu...
Of the 601 patients, 595 patients completed the PSQI assessment, with 278 patients having poor sleep quality. Patients in the PSQI > 7 group were older and had a higher proportion of cardiovascular di...
The prevalence of poor sleep quality was 46.7% in patients with MHD. Poor sleep quality was an independent risk factor for MACEs in patients with MHD....
Sleep disruption is common in older adults and is associated with many poor health outcomes. It is vital for providers to understand insomnia and other sleep disorders in this population. This article...